Skip to Main Navigation
Skip to Page Content
COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC and research information from NIH.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/9826

Target Organs and Levels of Evidence for TR-520

Toxicology and Carcinogenesis Studies of 3,3',4,4',5-Pentachlorobiphenyl (PCB 126) (CASRN 57465-28-8) in Female Harlan Sprague-Dawley Rats (Gavage Studies)

Chemical (Study Title)
CASRN		 Peer Review Date Route/Exposure Levels Study Laboratory
Toxic equivalency factor evaluation ((PCB 126) 3,3',4,4',5-pentachlorobiphenyl)
57465-28-8		 02/17/2004 Gavage
FEMALE RATS ONLY: PCB-126 -- 0, 10, 30, 100, 175, 300, 550, OR 1000 NG/KG; 100/DOSE		 Battelle Columbus Laboratory

Levels of Evidence

Female Rats: Clear Evidence
Type Organ/Tissue (Lesion)
Neoplastic Lesions
  • Liver: CHOLANGIOCARCINOMA 0/53 0/55 1/53 0/53 5/53 6/51 22/53 2/50 OR ADENOMA 1/53 2/55 1/53 0/53 2/53 4/51 7/53 0/50 OR HEPATOCHOLANGIOMA 0/53 0/55 0/53 0/53 0/53 0/51 3/53 0/50
  • Lung: CYSTIC KERATINIZING EPITHELIOMA 0/53 0/55 0/53 0/53 1/53 11/51 35/51 0/50 OR SQUAMOUS CELL CARCINOMA 0/53 0/55 0/53 0/53 0/53 1/51 2/51 0/50
  • Oral Cavity: GINGIVAL SQUAMOUS CELL CARINOMA (ORAL MUCOSA) 0/53 1/55 1/53 1/53 2/53 2/53 7/53 2/50
May Have Been Related
  • Adrenal Gland Cortex: ADENOMA OR CARCINOMA 0/52 2/55 1/53 0/53 1/53 1/52 4/53 3/50
  • Liver: CHOLANGIOMA 0/53 0/55 0/53 0/53 0/53 1/51 1/53 0/50
Non-Neoplastic Lesions
  • LIVER: HEPATOCYTE HYPERTROPHY; MULTINUCLEATED HEPATOCYTE; DIFFUSE FATTY CHANGE; BILE DUCT HYPERPLASIA; BILE DUCT CYST; OVAL CELL HYPERPLASIA; NECROSIS; PIGMENTATION; INFLAMMATION; NODULAR HYPERPLASIA; PORTAL FIBROSIS; CHOLANGIOFIBROSIS; TOXIC HEPATOPATHY
  • LUNG: ALVEOLAR EPITHELIUM, METAPLASIA, BRONCHIOLAR; SQUAMOUS METAPLASIA
  • ADRENAL CORTEX: ATROPHY; CYTOPLASMIC VACUOLIZATION
  • PANCREAS: CHRONIC ACTIVE INFLAMMATION; ACINAR ATROPHY; ACINAR CYTOPLASMIC VACUOLIZATION; ARTERIAL CHRONIC ACTIVE INFLAMMATION
  • KIDNEY: NEPHROPATHY; SEVERITY OF NEPHROPATHY
  • HEART: CARDIOMYOPATHY
  • THYROID GLAND: FOLLICULAR CELL HYPERTROPHY
  • THYMUS: ATROPHY; SEVERITY OF ATROPHY
  • SPLEEN: LYMPHOID FOLLICULAR ATROPHY
  • CLITORAL GLAND: CYSTIC DUCT
  • MESENTERY: ARTERIAL CHRONIC ACTIVE INFLAMMATION